AU2001297917B2 - Method for noninvasive continuous determination of physiologic characteristics - Google Patents
Method for noninvasive continuous determination of physiologic characteristics Download PDFInfo
- Publication number
- AU2001297917B2 AU2001297917B2 AU2001297917A AU2001297917A AU2001297917B2 AU 2001297917 B2 AU2001297917 B2 AU 2001297917B2 AU 2001297917 A AU2001297917 A AU 2001297917A AU 2001297917 A AU2001297917 A AU 2001297917A AU 2001297917 B2 AU2001297917 B2 AU 2001297917B2
- Authority
- AU
- Australia
- Prior art keywords
- log
- blood
- pulse
- arterial
- probe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000034 method Methods 0.000 title claims description 82
- 210000004369 blood Anatomy 0.000 claims description 165
- 239000008280 blood Substances 0.000 claims description 165
- 238000002835 absorbance Methods 0.000 claims description 85
- 229910052760 oxygen Inorganic materials 0.000 claims description 71
- 239000001301 oxygen Substances 0.000 claims description 71
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 69
- 108010054147 Hemoglobins Proteins 0.000 claims description 46
- 102000001554 Hemoglobins Human genes 0.000 claims description 46
- 230000005855 radiation Effects 0.000 claims description 28
- 239000000470 constituent Substances 0.000 claims description 13
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 12
- 239000008103 glucose Substances 0.000 claims description 12
- 239000006096 absorbing agent Substances 0.000 claims description 8
- 239000000523 sample Substances 0.000 description 172
- 230000000747 cardiac effect Effects 0.000 description 65
- 238000005259 measurement Methods 0.000 description 59
- 230000008859 change Effects 0.000 description 53
- 210000003811 finger Anatomy 0.000 description 45
- 230000002706 hydrostatic effect Effects 0.000 description 28
- 230000036772 blood pressure Effects 0.000 description 24
- 210000003371 toe Anatomy 0.000 description 19
- 230000008033 biological extinction Effects 0.000 description 15
- 230000000694 effects Effects 0.000 description 15
- 210000003414 extremity Anatomy 0.000 description 14
- 230000033001 locomotion Effects 0.000 description 14
- 210000004072 lung Anatomy 0.000 description 14
- 210000001367 artery Anatomy 0.000 description 13
- 238000000862 absorption spectrum Methods 0.000 description 12
- 238000012544 monitoring process Methods 0.000 description 12
- 230000008569 process Effects 0.000 description 12
- 108010003320 Carboxyhemoglobin Proteins 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 11
- 210000002683 foot Anatomy 0.000 description 11
- 210000005240 left ventricle Anatomy 0.000 description 11
- 108010061951 Methemoglobin Proteins 0.000 description 10
- 108010064719 Oxyhemoglobins Proteins 0.000 description 10
- 230000017531 blood circulation Effects 0.000 description 10
- 230000036541 health Effects 0.000 description 10
- 238000004364 calculation method Methods 0.000 description 9
- 230000007423 decrease Effects 0.000 description 9
- 238000003745 diagnosis Methods 0.000 description 9
- 210000004247 hand Anatomy 0.000 description 9
- 210000000056 organ Anatomy 0.000 description 9
- 238000002106 pulse oximetry Methods 0.000 description 9
- INGWEZCOABYORO-UHFFFAOYSA-N 2-(furan-2-yl)-7-methyl-1h-1,8-naphthyridin-4-one Chemical compound N=1C2=NC(C)=CC=C2C(O)=CC=1C1=CC=CO1 INGWEZCOABYORO-UHFFFAOYSA-N 0.000 description 8
- 210000000709 aorta Anatomy 0.000 description 8
- 235000013405 beer Nutrition 0.000 description 8
- 210000000038 chest Anatomy 0.000 description 8
- 108010002255 deoxyhemoglobin Proteins 0.000 description 8
- 230000002093 peripheral effect Effects 0.000 description 8
- 210000003462 vein Anatomy 0.000 description 8
- 238000011481 absorbance measurement Methods 0.000 description 7
- 230000004872 arterial blood pressure Effects 0.000 description 7
- 238000004422 calculation algorithm Methods 0.000 description 7
- 230000036961 partial effect Effects 0.000 description 7
- 230000000541 pulsatile effect Effects 0.000 description 7
- 238000001228 spectrum Methods 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 6
- 210000001715 carotid artery Anatomy 0.000 description 6
- 230000001934 delay Effects 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000006698 induction Effects 0.000 description 6
- 210000003141 lower extremity Anatomy 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000029058 respiratory gaseous exchange Effects 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical group [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- 208000018262 Peripheral vascular disease Diseases 0.000 description 5
- 206010003119 arrhythmia Diseases 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 230000002526 effect on cardiovascular system Effects 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 230000036387 respiratory rate Effects 0.000 description 5
- 210000003270 subclavian artery Anatomy 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000001356 surgical procedure Methods 0.000 description 5
- 206010006322 Breath holding Diseases 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 230000001133 acceleration Effects 0.000 description 4
- 238000009530 blood pressure measurement Methods 0.000 description 4
- 230000036770 blood supply Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000010494 dissociation reaction Methods 0.000 description 4
- 230000005593 dissociations Effects 0.000 description 4
- 210000003128 head Anatomy 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 238000002798 spectrophotometry method Methods 0.000 description 4
- 230000004075 alteration Effects 0.000 description 3
- 239000012491 analyte Substances 0.000 description 3
- 210000002376 aorta thoracic Anatomy 0.000 description 3
- 230000002567 autonomic effect Effects 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 206010010121 compartment syndrome Diseases 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 210000005069 ears Anatomy 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000000474 nursing effect Effects 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 210000005241 right ventricle Anatomy 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 230000002861 ventricular Effects 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 208000006179 Aortic Coarctation Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010009807 Coarctation of the aorta Diseases 0.000 description 2
- 208000028399 Critical Illness Diseases 0.000 description 2
- 108010044495 Fetal Hemoglobin Proteins 0.000 description 2
- 108010085682 Hemoglobin A Proteins 0.000 description 2
- 102000007513 Hemoglobin A Human genes 0.000 description 2
- 238000013494 PH determination Methods 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 238000002399 angioplasty Methods 0.000 description 2
- 108010000865 aquomethemoglobin Proteins 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 210000002565 arteriole Anatomy 0.000 description 2
- 230000001746 atrial effect Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000002302 brachial artery Anatomy 0.000 description 2
- 210000002168 brachiocephalic trunk Anatomy 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000013480 data collection Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 208000028867 ischemia Diseases 0.000 description 2
- 210000005246 left atrium Anatomy 0.000 description 2
- 239000002906 medical waste Substances 0.000 description 2
- 238000002496 oximetry Methods 0.000 description 2
- 238000006213 oxygenation reaction Methods 0.000 description 2
- 230000005298 paramagnetic effect Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 210000005245 right atrium Anatomy 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000036280 sedation Effects 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- 210000000264 venule Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- HQOWCDPFDSRYRO-CDKVKFQUSA-N CCCCCCc1ccc(cc1)C1(c2cc3-c4sc5cc(\C=C6/C(=O)c7ccccc7C6=C(C#N)C#N)sc5c4C(c3cc2-c2sc3cc(C=C4C(=O)c5ccccc5C4=C(C#N)C#N)sc3c12)(c1ccc(CCCCCC)cc1)c1ccc(CCCCCC)cc1)c1ccc(CCCCCC)cc1 Chemical compound CCCCCCc1ccc(cc1)C1(c2cc3-c4sc5cc(\C=C6/C(=O)c7ccccc7C6=C(C#N)C#N)sc5c4C(c3cc2-c2sc3cc(C=C4C(=O)c5ccccc5C4=C(C#N)C#N)sc3c12)(c1ccc(CCCCCC)cc1)c1ccc(CCCCCC)cc1)c1ccc(CCCCCC)cc1 HQOWCDPFDSRYRO-CDKVKFQUSA-N 0.000 description 1
- 101100275473 Caenorhabditis elegans ctc-3 gene Proteins 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- XXAXVMUWHZHZMJ-UHFFFAOYSA-N Chymopapain Chemical compound OC1=CC(S(O)(=O)=O)=CC(S(O)(=O)=O)=C1O XXAXVMUWHZHZMJ-UHFFFAOYSA-N 0.000 description 1
- 108090001069 Chymopapain Proteins 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 208000002330 Congenital Heart Defects Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 208000023281 Fallot tetralogy Diseases 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010058558 Hypoperfusion Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 208000035478 Interatrial communication Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 101100168274 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cox-3 gene Proteins 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000004605 Persistent Truncus Arteriosus Diseases 0.000 description 1
- 206010039203 Road traffic accident Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 201000003005 Tetralogy of Fallot Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010044443 Transposition of the great vessels Diseases 0.000 description 1
- 208000037258 Truncus arteriosus Diseases 0.000 description 1
- 208000001910 Ventricular Heart Septal Defects Diseases 0.000 description 1
- 206010047281 Ventricular arrhythmia Diseases 0.000 description 1
- 208000002223 abdominal aortic aneurysm Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 208000007474 aortic aneurysm Diseases 0.000 description 1
- 208000013914 atrial heart septal defect Diseases 0.000 description 1
- 206010003664 atrial septal defect Diseases 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 238000002555 auscultation Methods 0.000 description 1
- 230000010455 autoregulation Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 230000009084 cardiovascular function Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 208000006170 carotid stenosis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 208000028831 congenital heart disease Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 210000000624 ear auricle Anatomy 0.000 description 1
- 238000002565 electrocardiography Methods 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 238000002692 epidural anesthesia Methods 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 238000002683 hand surgery Methods 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000009532 heart rate measurement Methods 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000000870 hyperventilation Effects 0.000 description 1
- 208000000122 hyperventilation Diseases 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 210000003090 iliac artery Anatomy 0.000 description 1
- 238000012623 in vivo measurement Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000007620 mathematical function Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000005541 medical transmission Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000005486 microgravity Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- -1 nitrogen Chemical compound 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000002640 oxygen therapy Methods 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 208000003278 patent ductus arteriosus Diseases 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000004088 pulmonary circulation Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 210000003492 pulmonary vein Anatomy 0.000 description 1
- 230000035485 pulse pressure Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008672 reprogramming Effects 0.000 description 1
- 230000004202 respiratory function Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- HJORMJIFDVBMOB-UHFFFAOYSA-N rolipram Chemical compound COC1=CC=C(C2CC(=O)NC2)C=C1OC1CCCC1 HJORMJIFDVBMOB-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000002693 spinal anesthesia Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 210000002820 sympathetic nervous system Anatomy 0.000 description 1
- 230000001839 systemic circulation Effects 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 208000014903 transposition of the great arteries Diseases 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 201000003130 ventricular septal defect Diseases 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 230000021542 voluntary musculoskeletal movement Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
- A61B5/6825—Hand
- A61B5/6826—Finger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/02007—Evaluating blood vessel condition, e.g. elasticity, compliance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/02028—Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
- A61B5/02055—Simultaneously evaluating both cardiovascular condition and temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14539—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring pH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4821—Determining level or depth of anaesthesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/683—Means for maintaining contact with the body
- A61B5/6838—Clamps or clips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0242—Operational features adapted to measure environmental factors, e.g. temperature, pollution
- A61B2560/0247—Operational features adapted to measure environmental factors, e.g. temperature, pollution for compensation or correction of the measured physiological value
- A61B2560/0261—Operational features adapted to measure environmental factors, e.g. temperature, pollution for compensation or correction of the measured physiological value using hydrostatic pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02416—Detecting, measuring or recording pulse rate or heart rate using photoplethysmograph signals, e.g. generated by infrared radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/026—Measuring blood flow
- A61B5/0285—Measuring or recording phase velocity of blood waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/026—Measuring blood flow
- A61B5/029—Measuring or recording blood output from the heart, e.g. minute volume
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
- A61B5/14552—Details of sensors specially adapted therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/25—Bioelectric electrodes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/369—Electroencephalography [EEG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/389—Electromyography [EMG]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2001/046855 WO2003039326A2 (en) | 2001-11-07 | 2001-11-07 | Method for noninvasive continuous determination of physiologic characteristics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2001297917A1 AU2001297917A1 (en) | 2003-05-19 |
| AU2001297917B2 true AU2001297917B2 (en) | 2007-11-01 |
Family
ID=21743081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001297917A Ceased AU2001297917B2 (en) | 2001-11-07 | 2001-11-07 | Method for noninvasive continuous determination of physiologic characteristics |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1450672A4 (de) |
| JP (1) | JP2005507298A (de) |
| AU (1) | AU2001297917B2 (de) |
| CA (1) | CA2466012A1 (de) |
| MX (1) | MXPA04004286A (de) |
| WO (1) | WO2003039326A2 (de) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8932227B2 (en) | 2000-07-28 | 2015-01-13 | Lawrence A. Lynn | System and method for CO2 and oximetry integration |
| US9042952B2 (en) | 1997-01-27 | 2015-05-26 | Lawrence A. Lynn | System and method for automatic detection of a plurality of SPO2 time series pattern types |
| US9468378B2 (en) | 1997-01-27 | 2016-10-18 | Lawrence A. Lynn | Airway instability detection system and method |
| US9521971B2 (en) | 1997-07-14 | 2016-12-20 | Lawrence A. Lynn | System and method for automatic detection of a plurality of SPO2 time series pattern types |
| US20060195041A1 (en) | 2002-05-17 | 2006-08-31 | Lynn Lawrence A | Centralized hospital monitoring system for automatically detecting upper airway instability and for preventing and aborting adverse drug reactions |
| US9053222B2 (en) | 2002-05-17 | 2015-06-09 | Lawrence A. Lynn | Patient safety processor |
| GB0213836D0 (en) * | 2002-06-14 | 2002-07-24 | Electrode Company The Ltd | Analytical apparatus |
| KR100624412B1 (ko) | 2003-09-16 | 2006-09-18 | 삼성전자주식회사 | 혈중성분 측정장치 및 이를 이용한 혈중성분측정방법 |
| JP2006231012A (ja) * | 2005-01-28 | 2006-09-07 | Nippon Koden Corp | 酸素運搬の循環時間測定方法および装置 |
| US7674231B2 (en) | 2005-08-22 | 2010-03-09 | Massachusetts Institute Of Technology | Wearable pulse wave velocity blood pressure sensor and methods of calibration thereof |
| US7641614B2 (en) | 2005-08-22 | 2010-01-05 | Massachusetts Institute Of Technology | Wearable blood pressure sensor and method of calibration |
| US7869850B2 (en) | 2005-09-29 | 2011-01-11 | Nellcor Puritan Bennett Llc | Medical sensor for reducing motion artifacts and technique for using the same |
| US7904130B2 (en) | 2005-09-29 | 2011-03-08 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
| US8219170B2 (en) | 2006-09-20 | 2012-07-10 | Nellcor Puritan Bennett Llc | System and method for practicing spectrophotometry using light emitting nanostructure devices |
| US7574245B2 (en) | 2006-09-27 | 2009-08-11 | Nellcor Puritan Bennett Llc | Flexible medical sensor enclosure |
| US7684842B2 (en) | 2006-09-29 | 2010-03-23 | Nellcor Puritan Bennett Llc | System and method for preventing sensor misuse |
| ITMI20070464A1 (it) * | 2007-03-09 | 2008-09-10 | Vittorio Londoni | Dispositivo laser diodico per la determinazione incruenta della glicemia |
| US8265724B2 (en) | 2007-03-09 | 2012-09-11 | Nellcor Puritan Bennett Llc | Cancellation of light shunting |
| US8280469B2 (en) | 2007-03-09 | 2012-10-02 | Nellcor Puritan Bennett Llc | Method for detection of aberrant tissue spectra |
| US8750953B2 (en) | 2008-02-19 | 2014-06-10 | Covidien Lp | Methods and systems for alerting practitioners to physiological conditions |
| CA2722773C (en) | 2008-05-07 | 2015-07-21 | Lawrence A. Lynn | Medical failure pattern search engine |
| US8295567B2 (en) | 2008-06-30 | 2012-10-23 | Nellcor Puritan Bennett Ireland | Systems and methods for ridge selection in scalograms of signals |
| US9895068B2 (en) | 2008-06-30 | 2018-02-20 | Covidien Lp | Pulse oximeter with wait-time indication |
| US8968193B2 (en) | 2008-09-30 | 2015-03-03 | Covidien Lp | System and method for enabling a research mode on physiological monitors |
| WO2010051479A1 (en) | 2008-10-31 | 2010-05-06 | Nellcor Puritan Bennett Llc | System and method for facilitating observation of monitored physiologic data |
| US8313439B2 (en) | 2009-03-20 | 2012-11-20 | Massachusetts Institute Of Technology | Calibration of pulse transit time measurements to arterial blood pressure using external arterial pressure applied along the pulse transit path |
| CA2780005A1 (en) * | 2009-11-12 | 2011-05-19 | Nellcor Puritan Bennett Llc | Systems and methods for combined physiological sensors |
| JP5302257B2 (ja) * | 2010-04-05 | 2013-10-02 | 建夫 斎藤 | 組織血流量測定装置及び組織血流量測定用プログラム |
| CN101799412B (zh) * | 2010-04-07 | 2012-04-25 | 中国科学院自动化研究所 | 无创测量人体血糖的近红外光谱透射方法及装置 |
| US8610769B2 (en) | 2011-02-28 | 2013-12-17 | Covidien Lp | Medical monitor data collection system and method |
| EP2782496A4 (de) * | 2012-01-30 | 2015-08-05 | Duncan Campbell Invest Pty Ltd | Verfahren und vorrichtung zur nichtinvasiven bestimmung des herzzeitvolumens |
| US8880155B2 (en) | 2012-02-24 | 2014-11-04 | Covidien Lp | Hypovolemia diagnosis technique |
| US11399898B2 (en) | 2012-03-06 | 2022-08-02 | Briteseed, Llc | User interface for a system used to determine tissue or artifact characteristics |
| US9693697B2 (en) | 2012-03-29 | 2017-07-04 | Benny Tal | Hand-held device having health monitoring capabilities |
| CN103505190B (zh) * | 2012-06-18 | 2015-02-25 | 美盛医电股份有限公司 | 测量装置 |
| US10827961B1 (en) | 2012-08-29 | 2020-11-10 | Masimo Corporation | Physiological measurement calibration |
| US9241646B2 (en) | 2012-09-11 | 2016-01-26 | Covidien Lp | System and method for determining stroke volume of a patient |
| JP6055688B2 (ja) * | 2013-01-31 | 2016-12-27 | 日本光電工業株式会社 | 生体信号測定システム、生体信号測定装置、および生体信号測定装置の制御プログラム |
| WO2014198868A1 (en) * | 2013-06-13 | 2014-12-18 | Koninklijke Philips N.V. | Device and method for determining a partial carbon dioxide pressure in a subject of interest |
| WO2015148504A1 (en) | 2014-03-25 | 2015-10-01 | Briteseed Llc | Vessel detector and method of detection |
| WO2016134327A1 (en) | 2015-02-19 | 2016-08-25 | Briteseed Llc | System for determining vessel size using light absorption |
| WO2016134330A1 (en) | 2015-02-19 | 2016-08-25 | Briteseed Llc | System and method for determining vessel size and/or edge |
| WO2017062720A1 (en) | 2015-10-08 | 2017-04-13 | Briteseed Llc | System and method for determining vessel size |
| EP3413792B1 (de) * | 2016-02-12 | 2023-12-13 | Briteseed, LLC | Bestimmung des vorhandenseins eines gefässes innerhalb eines bereichs in der nähe eines arbeitsendes eines chirurgischen instruments |
| DE102016109694A1 (de) * | 2016-05-25 | 2017-11-30 | Osram Opto Semiconductors Gmbh | Sensorvorrichtung |
| WO2018044722A1 (en) | 2016-08-30 | 2018-03-08 | Briteseed Llc | System and method for determining vessel size with angular distortion compensation |
| KR102446394B1 (ko) * | 2016-11-17 | 2022-09-22 | 메디치 테크놀로지스, 엘엘씨 | 중심 정맥압 측정 상태를 위한 방법 및 장치 |
| WO2019050928A1 (en) | 2017-09-05 | 2019-03-14 | Briteseed, Llc | SYSTEM AND METHOD USED TO DETERMINE TISSUE AND / OR ARTIFACT CHARACTERISTICS |
| US11696777B2 (en) | 2017-12-22 | 2023-07-11 | Briteseed, Llc | Compact system used to determine tissue or artifact characteristics |
| MX2021010284A (es) * | 2019-02-26 | 2021-12-10 | Digital Blood Corp | Sistema para examen no invasivo de parámetros del ambiente en sangre. |
| US20230270343A1 (en) * | 2020-07-17 | 2023-08-31 | Board Of Trustees Of Michigan State University | Techniques for screening and monitoring patients for aortic aneurysms |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5638816A (en) * | 1995-06-07 | 1997-06-17 | Masimo Corporation | Active pulse blood constituent monitoring |
| WO2001024845A2 (en) * | 1999-10-07 | 2001-04-12 | Mills Alexander K | Method and apparatus for non-invasive continuous determination of physiological parameters of a patient's blood |
| US6222189B1 (en) * | 1992-07-15 | 2001-04-24 | Optix, Lp | Methods of enhancing optical signals by mechanical manipulation in non-invasive testing |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4968137A (en) * | 1986-12-05 | 1990-11-06 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon Health Sciences University | Devices and procedures for in vitro testing of pulse oximetry monitors |
| US5372136A (en) * | 1990-10-06 | 1994-12-13 | Noninvasive Medical Technology Corporation | System and method for noninvasive hematocrit monitoring |
| JP3116252B2 (ja) * | 1992-07-09 | 2000-12-11 | 日本光電工業株式会社 | パルスオキシメータ |
| AU3721997A (en) * | 1996-07-19 | 1998-02-10 | Alexander K. Mills | Device for noninvasive determination of blood parameters |
| JP3856477B2 (ja) * | 1996-10-24 | 2006-12-13 | マサチューセッツ・インスティテュート・オブ・テクノロジー | 患者監視指輪センサ |
| JP2002516689A (ja) * | 1998-06-03 | 2002-06-11 | マシモ・コーポレイション | ステレオパルスオキシメータ |
-
2001
- 2001-11-07 WO PCT/US2001/046855 patent/WO2003039326A2/en active Application Filing
- 2001-11-07 AU AU2001297917A patent/AU2001297917B2/en not_active Ceased
- 2001-11-07 EP EP01274207A patent/EP1450672A4/de not_active Withdrawn
- 2001-11-07 JP JP2003541424A patent/JP2005507298A/ja active Pending
- 2001-11-07 CA CA002466012A patent/CA2466012A1/en not_active Abandoned
- 2001-11-07 MX MXPA04004286A patent/MXPA04004286A/es active IP Right Grant
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6222189B1 (en) * | 1992-07-15 | 2001-04-24 | Optix, Lp | Methods of enhancing optical signals by mechanical manipulation in non-invasive testing |
| US5638816A (en) * | 1995-06-07 | 1997-06-17 | Masimo Corporation | Active pulse blood constituent monitoring |
| WO2001024845A2 (en) * | 1999-10-07 | 2001-04-12 | Mills Alexander K | Method and apparatus for non-invasive continuous determination of physiological parameters of a patient's blood |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2001297917A1 (en) | 2003-05-19 |
| WO2003039326A3 (en) | 2003-07-24 |
| WO2003039326A2 (en) | 2003-05-15 |
| CA2466012A1 (en) | 2003-05-15 |
| EP1450672A4 (de) | 2005-06-22 |
| MXPA04004286A (es) | 2004-09-10 |
| EP1450672A2 (de) | 2004-09-01 |
| WO2003039326A8 (en) | 2007-09-07 |
| JP2005507298A (ja) | 2005-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001297917B2 (en) | Method for noninvasive continuous determination of physiologic characteristics | |
| US6819950B2 (en) | Method for noninvasive continuous determination of physiologic characteristics | |
| AU766952B2 (en) | Device and method for noninvasive continuous determination of physiologic characteristics | |
| Webster | Design of pulse oximeters | |
| EP1469773B1 (de) | Venöse pulsoxymetrie | |
| US7044917B2 (en) | Method and apparatus for measuring pulsus paradoxus | |
| US6709402B2 (en) | Apparatus and method for monitoring respiration with a pulse oximeter | |
| EP1332713A1 (de) | Venöser Pulsoxymetrie | |
| Budidha | In vivo investigations of photoplethysmograms and arterial oxygen saturation from the auditory canal in conditions of compromised peripheral perfusion | |
| Alzahrani | A reflectance opto-electronic patch sensor for physiological monitoring with motion artefacts reduction | |
| Katan et al. | Self-calibrated biosensor for measuring multiple physiological parameters | |
| Chan | Non-invasive venous oximetry through venous blood volume modulation | |
| Mohler et al. | Use of a pulse oximeter for determination of systolic blood pressure in a helicopter air ambulance | |
| Cloete | Non-invasive artificial pulse oximetry: development & testing | |
| Subramanian | Real time perfusion and oxygenation monitoring in an implantable optical sensor | |
| Abu Shokor et al. | Design of a Wearable Device for Noninvasive Cardiovascular Measurements (SPO2, heart rate and blood pressure) | |
| Mould | C zyxwvutsrqponmlkjihg | |
| Wolf | The measurement of the oxygenation status of the newborn infant | |
| Dirks | The validity of the pulse oximeter in critically ill hemodynamically compromised patients |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |